Cargando…
Horizons on the Therapy of Biliary Tract Cancers: A State-of-the-art Review
Biliary tract cancers (BTCs) comprise a group of heterogeneous poor prognosis cancers with increasing incidence recent years. The combination chemotherapy with cisplatin and gemcitabine is the first-line therapy for advanced BTC. There remains no accepted standard treatment in the second-line settin...
Autores principales: | Xue, Ran, Li, Rong, Wang, Jianxin, Tong, Weiping, Hao, Jianyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
XIA & HE Publishing Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369023/ https://www.ncbi.nlm.nih.gov/pubmed/34447686 http://dx.doi.org/10.14218/JCTH.2021.00007 |
Ejemplares similares
-
Neoadjuvant treatment of biliary tract cancer: state-of-the-art and new perspectives
por: Imperatori, Marco, et al.
Publicado: (2016) -
Systemic Treatment for Metastatic Biliary Tract Cancer: State of the Art and a Glimpse to the Future
por: Rizzo, Alessandro, et al.
Publicado: (2022) -
Targeted Therapy for Biliary Tract Cancer
por: Furuse, Junji, et al.
Publicado: (2011) -
Adjuvant therapy of biliary tract cancers
por: Kefas, Joanna, et al.
Publicado: (2023) -
Combination Therapies for Advanced Biliary Tract Cancer
por: Zeng, Weifeng, et al.
Publicado: (2023)